Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bristol-Myers Squibb signs development deal for rheumatoid arthritis drug with Alder Biopharma
Yahoo/AP
Tuesday, November 10, 2009 - 8:59am
tags:
Alder Biopharma, Bristol-Myers Squibb, rheumatoid arthritis
The Real Price of Big Pharma's Huge Fines
Seeking Alpha
Tuesday, November 10, 2009 - 8:52am
tags:
Big Pharma, Pfizer, Bristol-Myers Squibb, Eli Lilly, Schering Plough
Merck Cholesterol Pill Sales May Drop 20% More on Study Finding
Bloomberg
Tuesday, November 10, 2009 - 8:50am
tags:
Merck, Zetia, Vytorin, cholesterol
Why I'm Still Buying Johnson & Johnson at These Levels
Seeking Alpha
Tuesday, November 10, 2009 - 8:48am
tags:
JNJ
Guidant: The Gift That Keeps on Giving
Motley Fool
Monday, November 9, 2009 - 5:44pm
tags:
Guidant
J&J Axes Evolence, Its "Too Lumpy" Dermal Filler; Allergan, Medicis Rejoice
BNET Pharma
Monday, November 9, 2009 - 3:29pm
tags:
Allergan, Medicis, JNJ, dermal fillers, Evolence
Three Core Biotech Holdings: Isis, Ligand and Vical
Seeking Alpha
Monday, November 9, 2009 - 3:27pm
tags:
Isis Pharmaceuticals, Ligand, Vical, biotech
Generics Makers Line Up To Sell Copies Of Pfizer's Lipitor
CNN Money
Monday, November 9, 2009 - 3:16pm
tags:
generics, patents, Pfizer, Lipitor, Dr Reddy's
Cypress Bioscience says 3rd-quarter loss grew due to costs connected to launch of Savella
Yahoo/AP
Monday, November 9, 2009 - 3:15pm
tags:
Savella, Cypress Bioscience, earnings
Pfizer to shutter six out of 20 R&D sites
Marketwatch
Monday, November 9, 2009 - 3:13pm
tags:
Pfizer, reorganization, R&D
Ranbaxy: FDA Issues Will Take Long Time To Resolve
WSJ Online
Monday, November 9, 2009 - 11:26am
tags:
India, Ranbaxy, FDA, Daiichi Sankyo
Enzon sells specialty drug business for $300M
Yahoo/AP
Monday, November 9, 2009 - 11:24am
tags:
Enzon, M&A, Sigma-Tau
Insurers, Drugmakers Turn to Senate for Health-Bill Changes
Bloomberg
Monday, November 9, 2009 - 11:24am
tags:
healthcare reform, healthcare bill
200 pharma whistleblowers in line for court
Fierce Pharma
Monday, November 9, 2009 - 11:22am
tags:
whistleblowers
Xoma Waffles on Timing of Drug Partnership
TheStreet.com
Monday, November 9, 2009 - 11:20am
tags:
Xoma, XOMA 052
Pfizer Aiming for 30,900 Layoffs Through 2012
BNET Pharma
Monday, November 9, 2009 - 10:27am
tags:
Pfizer, layoffs
Despite Omeros Flop, Trius and Other Biotech IPO Hopefuls Might Fare Better
BNET Pharma
Monday, November 9, 2009 - 10:25am
tags:
IPOs, Trius Therapeutics, Omeros
Forest Laboratories: Steady Growth in Sales and Earnings
Seeking Alpha
Monday, November 9, 2009 - 10:13am
tags:
Forest Labs, earnings
Cephalon's Upside and Downside
Seeking Alpha
Monday, November 9, 2009 - 10:12am
tags:
Cephalon, Teva Pharmaceuticals, Watson Pharmaceuticals
XenoPort and Glaxo says FDA review of neuropathic pain drug extended 3 months, to Feb. 2010
Yahoo/AP
Monday, November 9, 2009 - 10:09am
tags:
XenoPort, FDA, GSK, neuropathic pain

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.